AKT1 and Miyoshi myopathy: FASN, a key enzyme in fatty acid de novo synthesis highly expressed in MM cells, when inhibited, leads to reduced palmitate synthesis, disrupted lipid raft structure, and impaired pro - survival signaling like the AKT/mTOR pathway.